The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research report: Human SCGB1C2 (UniProt P0DMR2) functional annotation

1) Identity verification and gene-symbol ambiguity control

SCGB1C2 is the HGNC/Ensembl-approved symbol for “secretoglobin family 1C member 2” (OpenTargets lists target ENSG00000268320, approvedName “secretoglobin family 1C member 2”), consistent with the UniProt description provided in the prompt. (OpenTargets Search: -SCGB1C2)

A major practical issue for SCGB1C2 is extreme sequence similarity to SCGB1C1, which can cause mis-assignment in proteomics and complicates literature interpretation. In a chromosome 17 “missing proteins” analysis, the authors state that all tryptic peptides (≥9 aa) from SCGB1C2 overlap with variants of SCGB1C1, and that SCGB1C2 can be “completely subsumed by” SCGB1C1, making MS-based validation impractical. (siddiqui2018chromosome17missing pages 7-8)

Implication for this report: many datasets may report “secretoglobin family 1C member 1” (SCGB1C1) and not SCGB1C2, or may be unable to uniquely distinguish the two at the peptide level; evidence must therefore be treated cautiously and must explicitly name SCGB1C2 to be considered direct evidence. (siddiqui2018chromosome17missing pages 7-8)

2) Key concepts and definitions (current understanding)

Secretoglobins are a family of small, secreted proteins (classically including uteroglobin/SCGB1A1 family members) often discussed as extracellular, dimeric proteins implicated in mucosal biology and ligand binding in related family members. In the sources retrievable here, SCGB1C2-specific functional biochemistry (substrate/ligand specificity, catalytic activity, receptor binding) was not directly reported; therefore, no enzyme reaction, transporter substrate, or specific pathway position can be asserted from primary evidence in this session.

A critical proteomics concept relevant to SCGB1C2 is a proteotypic peptide: a peptide uniquely mapping to a single protein/gene product in MS-based proteomics. The Siddiqui et al. chromosome 17 analysis emphasizes that SCGB1C2 lacks proteotypic peptides (under trypsin and likely other proteases) because of overlap with SCGB1C1, limiting protein-level confirmation via standard MS approaches. (siddiqui2018chromosome17missing pages 7-8)

3) What is experimentally supported about SCGB1C2 from retrieved literature

3.1 Protein-level detectability (“missing protein” context)

In the neXtProt/Chromosome-centric Human Proteome Project context, SCGB1C2 is highlighted as a case where MS confirmation is technically impeded:
- All SCGB1C2 tryptic peptides (≥9 aa) overlap with SCGB1C1 variants, meaning peptide evidence cannot uniquely support SCGB1C2 protein existence.
- Considering alternative proteases (e.g., LysC) is discussed, but the authors conclude that for such highly similar gene families, “MS with any protease does not seem fruitful”, and that alternative methods beyond MS are needed. (siddiqui2018chromosome17missing pages 7-8)

3.2 Expression/disease-context evidence in recent clinical proteomics: note SCGB1C1 vs SCGB1C2

A 2024 nasal lavage fluid proteomics study in chronic rhinosinusitis with nasal polyposis (CRSwNP) reports strong down-regulation of SCGB1C1 (secretoglobin family 1C member 1) among the top dysregulated proteins (Table 2), with an abundance ratio (CRSwNP)/(CONTROL) of −18.52 (log2 ratio −4.22), p=0.00276391, adjusted p=0.0319461. (kashoob2024labelfreequantitativeproteomics pages 6-9)

However, this study’s visible tables/figures and search results in the retrieved context did not show SCGB1C2, so it cannot be treated as direct evidence for SCGB1C2 in CRSwNP. (kashoob2024labelfreequantitativeproteomics pages 6-9, kashoob2024labelfreequantitativeproteomics media 303cbbfe, kashoob2024labelfreequantitativeproteomics media 5cce52de)

4) Recent developments (prioritizing 2023–2024) and “latest research” status

Within the 2023–2024 primary literature retrieved in this session, direct SCGB1C2-focused functional studies were not found. Instead, the most concrete SCGB1C2-relevant progress is methodological/interpretive: the proteome-project literature emphasizes why SCGB1C2 is hard to validate at the protein level due to peptide non-uniqueness relative to SCGB1C1. (siddiqui2018chromosome17missing pages 7-8)

A 2024 asthma-related extracellular vesicle (EV) study explicitly lists Scgb1c1 among genes increased by adipose stem cell-derived EVs in an allergic airway inflammation model, but does not mention Scgb1c2, reinforcing the need to avoid cross-gene extrapolation. (jung2024paraoxonase1isa pages 5-6, jung2024paraoxonase1isa pages 1-2)

5) Current applications and real-world implementations

Biomarker discovery pipelines in airway disease increasingly use proteomics of nasal lavage fluid. In CRSwNP, the 2024 proteomics study demonstrates practical biomarker-model development (e.g., multivariate discrimination via OPLS-DA with R2Y=0.987 and Q2=0.657 in a referenced larger dataset, n=100), and uses significance cutoffs FDR p≤0.05 and fold change ≥1.5 for volcano-plot based dysregulation calls. (kashoob2024labelfreequantitativeproteomics pages 6-9, kashoob2024labelfreequantitativeproteomics media 303cbbfe, kashoob2024labelfreequantitativeproteomics media 5cce52de)

Despite being in the same broader family context, SCGB1C2 itself was not shown as a measured/quantified marker in the retrieved CRSwNP proteomics evidence; practical implementation evidence here is therefore indirect and applies to SCGB1C-family measurements generally, not SCGB1C2 specifically. (kashoob2024labelfreequantitativeproteomics pages 6-9)

6) Expert opinion / authoritative analysis (from retrievable sources)

The chromosome-centric proteomics analysis provides an authoritative explanation for why SCGB1C2 remains difficult to characterize at the protein level: in highly similar gene families, MS-based validation can fail because the gene’s peptides are not unique, and in SCGB1C2’s case the sequence evidence is “completely subsumed” by SCGB1C1. This is a concrete expert assessment of a key barrier to functional annotation and experimental validation. (siddiqui2018chromosome17missing pages 7-8)

7) Disease associations and statistics (database-derived, requires follow-up to underlying paper)

OpenTargets reports disease-target associations for SCGB1C2 including lens disease (score ~0.412), cataract (~0.378), senile cataract (~0.298), chronic fatigue syndrome (~0.0366), and glomerulonephritis (~0.0258), each with evidence size 3, and linked to literature PMID 40770095. (OpenTargets Search: -SCGB1C2)

These associations should be interpreted as hypothesis-generating until the underlying PMID is directly reviewed (not retrievable in this session via the paper-search tool). (OpenTargets Search: -SCGB1C2)

8) Summary of evidence compiled in this session

Table: This table compiles the specific SCGB1C2 evidence available in the retrieved context, separating true SCGB1C2 findings from frequent SCGB1C1-related ambiguity. It is useful for showing that direct functional literature is limited and that proteomics evidence is constrained by sequence overlap.

9) Key limitations of the current evidence base (for SCGB1C2 specifically)

1. Protein-level distinguishability problem: SCGB1C2 cannot be uniquely validated by standard MS peptide evidence due to overlap with SCGB1C1, which also increases the risk that proteomics “hits” are assigned to SCGB1C1 rather than SCGB1C2. (siddiqui2018chromosome17missing pages 7-8)
2. Sparse SCGB1C2-specific functional literature retrieved: No direct biochemical function, ligand specificity, or pathway placement for SCGB1C2 was found in the 2023–2024 literature retrievable here.
3. Database associations not yet traceable to primary evidence: OpenTargets points to PMID 40770095, but that underlying publication could not be retrieved here; thus the mechanistic or experimental basis of those disease links cannot be evaluated in this session. (OpenTargets Search: -SCGB1C2)

References (URLs and publication dates available in retrieved context)

• Siddiqui O, Zhang H, Guan Y, Omenn GS. Chromosome 17 Missing Proteins: Recent Progress and Future Directions as Part of the neXt-MP50 Challenge. Journal of Proteome Research. Oct 2018. https://doi.org/10.1021/acs.jproteome.8b00442 (siddiqui2018chromosome17missing pages 7-8)
• Kashoob M, Masood A, Alfadda AA, et al. Label-Free Quantitative Proteomics Analysis of Nasal Lavage Fluid in Chronic Rhinosinusitis with Nasal Polyposis. Biology. Oct 2024. https://doi.org/10.3390/biology13110887 (kashoob2024labelfreequantitativeproteomics pages 6-9, kashoob2024labelfreequantitativeproteomics media 303cbbfe, kashoob2024labelfreequantitativeproteomics media 5cce52de)
• Jung JH, Kang SA, Park J-H, et al. Paraoxonase-1 Is a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation Through Adipose Stem Cell-Derived Extracellular Vesicles. International Journal of Molecular Sciences. Nov 2024. https://doi.org/10.3390/ijms252312756 (jung2024paraoxonase1isa pages 5-6, jung2024paraoxonase1isa pages 1-2)
• OpenTargets disease-target association output for SCGB1C2 / ENSG00000268320 (retrieved in this session; underlying literature listed as PMID 40770095). (OpenTargets Search: -SCGB1C2)

References

1. (OpenTargets Search: -SCGB1C2): Open Targets Query (-SCGB1C2, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

2. (siddiqui2018chromosome17missing pages 7-8): Omer Siddiqui, Hongjiu Zhang, Yuanfang Guan, and Gilbert S. Omenn. Chromosome 17 missing proteins: recent progress and future directions as part of the next-mp50 challenge. Journal of proteome research, 17 12:4061-4071, Oct 2018. URL: https://doi.org/10.1021/acs.jproteome.8b00442, doi:10.1021/acs.jproteome.8b00442. This article has 7 citations and is from a peer-reviewed journal.

3. (kashoob2024labelfreequantitativeproteomics pages 6-9): Musallam Kashoob, Afshan Masood, Assim A. Alfadda, Salini Scaria Joy, Wed Alluhaim, Shahid Nawaz, Mashal Abaalkhail, Omar Alotaibi, Saad Alsaleh, and Hicham Benabdelkamel. Label-free quantitative proteomics analysis of nasal lavage fluid in chronic rhinosinusitis with nasal polyposis. Biology, 13:887, Oct 2024. URL: https://doi.org/10.3390/biology13110887, doi:10.3390/biology13110887. This article has 5 citations.

4. (kashoob2024labelfreequantitativeproteomics media 303cbbfe): Musallam Kashoob, Afshan Masood, Assim A. Alfadda, Salini Scaria Joy, Wed Alluhaim, Shahid Nawaz, Mashal Abaalkhail, Omar Alotaibi, Saad Alsaleh, and Hicham Benabdelkamel. Label-free quantitative proteomics analysis of nasal lavage fluid in chronic rhinosinusitis with nasal polyposis. Biology, 13:887, Oct 2024. URL: https://doi.org/10.3390/biology13110887, doi:10.3390/biology13110887. This article has 5 citations.

5. (kashoob2024labelfreequantitativeproteomics media 5cce52de): Musallam Kashoob, Afshan Masood, Assim A. Alfadda, Salini Scaria Joy, Wed Alluhaim, Shahid Nawaz, Mashal Abaalkhail, Omar Alotaibi, Saad Alsaleh, and Hicham Benabdelkamel. Label-free quantitative proteomics analysis of nasal lavage fluid in chronic rhinosinusitis with nasal polyposis. Biology, 13:887, Oct 2024. URL: https://doi.org/10.3390/biology13110887, doi:10.3390/biology13110887. This article has 5 citations.

6. (jung2024paraoxonase1isa pages 5-6): Jae Hoon Jung, Shin Ae Kang, Ji-Hwan Park, Sung-Dong Kim, Hak Sun Yu, Sue Jean Mun, and Kyu-Sup Cho. Paraoxonase-1 is a pivotal regulator responsible for suppressing allergic airway inflammation through adipose stem cell-derived extracellular vesicles. International Journal of Molecular Sciences, 25:12756, Nov 2024. URL: https://doi.org/10.3390/ijms252312756, doi:10.3390/ijms252312756. This article has 3 citations.

7. (jung2024paraoxonase1isa pages 1-2): Jae Hoon Jung, Shin Ae Kang, Ji-Hwan Park, Sung-Dong Kim, Hak Sun Yu, Sue Jean Mun, and Kyu-Sup Cho. Paraoxonase-1 is a pivotal regulator responsible for suppressing allergic airway inflammation through adipose stem cell-derived extracellular vesicles. International Journal of Molecular Sciences, 25:12756, Nov 2024. URL: https://doi.org/10.3390/ijms252312756, doi:10.3390/ijms252312756. This article has 3 citations.

Artifacts

• Edison artifact artifact-00
  

Citations

1. kashoob2024labelfreequantitativeproteomics pages 6-9
2. https://doi.org/10.1021/acs.jproteome.8b00442
3. https://doi.org/10.3390/biology13110887
4. https://doi.org/10.3390/ijms252312756
5. https://doi.org/10.1021/acs.jproteome.8b00442,
6. https://doi.org/10.3390/biology13110887,
7. https://doi.org/10.3390/ijms252312756,

Gene and Family Overview: SCGB1C2 (also known as secretoglobin family 1C member 1-like) is a human gene encoding a small secreted protein in the secretoglobin (SCGB) superfamily (www.genecards.org). This gene is located on chromosome 17 and is a paralog of SCGB1C1 (www.genecards.org). Secretoglobins are a family of mammalian secretory proteins (~10 kDa) that typically form dimers and were historically called the uteroglobin family (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). SCGB1C2 is a protein-coding gene (UniProt P0DMR2) and current genomic resources (updated 2025) predict its product is localized to the extracellular region (www.genecards.org) (www.genecards.org). Like other secretoglobins, SCGB1C2 contains a signal peptide for secretion and is expected to function outside the cell. Importantly, secretoglobins share a characteristic four-α-helix bundle structure in each monomer, assembling into homo- or heterodimers via conserved disulfide bonds (pmc.ncbi.nlm.nih.gov). This dimerization creates an internal hydrophobic cavity analogous to a globin fold, which can bind small lipophilic ligands (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).

Structural Features and Ligand Binding: By homology, the SCGB1C2 protein is comprised of about 90–100 amino acids including the signal sequence (the mature secreted form is roughly 10 kDa) (www.proteinatlas.org). Secretoglobin family members are known to be exceptionally stable dimers, resistant to proteases and extremes of pH (pmc.ncbi.nlm.nih.gov). Crystallographic studies on related secretoglobins (e.g. uteroglobin SCGB1A1) show two monomers arranged anti-parallel, enclosing a hydrophobic pocket (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This pocket is the key to function: for example, SCGB1A1 (Clara cell 10 kDa protein) binds a variety of hydrophobic molecules including steroid hormones, retinoids, certain polychlorinated biphenyl (PCB) metabolites, and eicosanoid inflammatory mediators (pmc.ncbi.nlm.nih.gov). Such binding capacity underlies the modulation of local ligand availability. Another family member, SCGB1C1, is highly similar to SCGB1C2 and has been identified in olfactory mucosa, where it localizes to Bowman’s glands and is thought to act as an odorant-binding protein (pmc.ncbi.nlm.nih.gov). SCGB1C1 (originally termed “ligand-binding protein RYD5”) binds small hydrophobic odorant molecules in the nasal mucus (pmc.ncbi.nlm.nih.gov). By analogy, SCGB1C2 likely shares this ligand-binding function, though its specific binding partners are not yet confirmed. The InterPro database classifies SCGB1C2 in the secretoglobin_1C-like family, reflecting a conserved fold and ligand-binding domain (www.genecards.org). In summary, the primary molecular function of SCGB1C2 is inferred to be binding and transport of small hydrophobic compounds in the extracellular milieu, similar to other secretoglobins (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This could include lipophilic signaling molecules or chemical messengers, consistent with the family’s role as “secreted ligand carriers.” Notably, secretoglobins have been described as multi-functional, cytokine-like modulators; for instance, SCGB1A1 has a peptide segment (“antiflammin”) that can inhibit phospholipase A2 and reduce inflammation (pmc.ncbi.nlm.nih.gov). While SCGB1C2 has not been fully biochemically characterized, its high sequence homology to SCGB1C1 suggests a comparable folded structure and capacity to bind ligands, potentially contributing to local chemical signaling or immune modulation.

Expression Profile and Localization: Experimental expression data indicate that SCGB1C2 is produced in specific tissues, aligning with a localized function. According to the Human Protein Atlas (HPA, v23, 2023), SCGB1C2 mRNA is most enriched in the pancreas, retina, and testis (www.proteinatlas.org). In normal tissue panels, SCGB1C2 shows “tissue-enhanced” expression in the exocrine pancreas (www.proteinatlas.org). Notably, single-cell RNA sequencing data reveal group-enriched expression in certain retinal cell types (Müller glial cells and photoreceptor cells) and in male germ cells (spermatocytes and spermatids) (www.proteinatlas.org) (www.proteinatlas.org). This suggests SCGB1C2 may have specialized roles in ocular and reproductive physiology. By contrast, SCGB1C2 transcripts are undetectable in adult brain tissue and most other organs, indicating a rather restricted expression pattern (www.proteinatlas.org). Such specificity is common for secretoglobins, which are often prominent in glandular or mucosal tissues. For example, many SCGB genes are highly expressed in secretory epithelia of the lung, lacrimal gland, salivary gland, uterus, and prostate (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Consistent with its classification, SCGB1C2 is a secreted protein: it contains a signal peptide and is exported out of the cell. It has been experimentally detected at the protein level (e.g. by mass-spectrometry or antibody-based assays), confirming that the predicted polypeptide is indeed expressed in human tissues (www.proteinatlas.org). Once synthesized and folded in the endoplasmic reticulum, SCGB1C2 is secreted into the extracellular space – likely into local glandular fluids or tissue interstitium – rather than being a membrane-bound or intracellular protein (www.proteinatlas.org). The Alliance of Genome Resources (2025) likewise annotates SCGB1C2 as an extracellular protein, indicating consensus that it functions outside the cell (www.genecards.org). Importantly, SCGB1C2 appears to act locally (“locally secreted”) rather than as a widely circulating hormone (www.proteinatlas.org). This means its effect is probably confined to the vicinity of the cells that produce it, such as the lumen of exocrine glands or the extracellular environment of retina and seminiferous tubules. In the retina, Müller glia and photoreceptors secreting SCGB1C2 could influence the retinal extracellular milieu – perhaps by binding retinoids or mitigating oxidative lipids – although direct evidence is lacking. In the testis, late spermatogenic cells expressing SCGB1C2 might release it into seminiferous tubule fluid, suggesting a role in the reproductive microenvironment (for example, binding and sequestering lipophilic factors or pheromone-like compounds). In the pancreas, SCGB1C2 is likely produced by acinar cells (which share features with other secretory epithelia) and secreted into pancreatic fluids or the extracellular space of the gland. While the precise sites of action remain to be pinpointed, the consistent theme is that SCGB1C2 operates in secretory fluids at tissue interfaces, aligning with a role in local chemical transport or defense.

Biological Function and Pathways: The exact biological role of SCGB1C2 is still under investigation, as there have been no dedicated functional studies on this protein to date. However, inference from closely related proteins and general secretoglobin biology provides valuable clues. Secretoglobins are often involved in modulating inflammation, immune responses, and tissue homeostasis (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). A comprehensive review of the human SCGB gene superfamily (Jackson et al., 2011) emphasized that most secretoglobins have poorly defined functions but collectively appear to play important roles in inflammation control, tissue repair, and tumorigenesis (pmc.ncbi.nlm.nih.gov). In particular, several secretoglobins act as immunomodulators or anti-inflammatory agents in their tissue contexts. For example, SCGB1A1 (uteroglobin/CC10) is a well-studied secretoglobin from airway Club cells that has anti-inflammatory and immunosuppressive effects in the lung. It can bind pro-inflammatory mediators (like leukotrienes and phospholipids) and thereby reduce inflammatory signaling (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Mice lacking SCGB1A1 show heightened lung inflammation, underscoring its protective role. Likewise, SCGB3A2 (UGRP1) in the lung has been shown to suppress allergic inflammation and promote tissue repair; it acts as both an anti-inflammatory cytokine and a growth factor in pulmonary disease models (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These examples illustrate how secretoglobins can influence signaling pathways: not by classical enzyme catalysis or receptor activity, but by binding ligands or interacting with cells in a cytokine-like manner.

Given this context, it is plausible that SCGB1C2’s primary function is to bind and sequester specific small molecules, thus regulating their availability and activity. The nature of such ligands for SCGB1C2 is not yet known. However, considering its expression sites, candidates could include retinoids or other lipid mediators in the retina, endogenous steroids or vitamins in the testis, or local inflammatory lipid mediators in glandular secretions. For instance, retinal Müller glia support neurons partly by controlling the extracellular chemical environment; SCGB1C2 could contribute by binding excess hydrophobic molecules or oxidative byproducts. In the olfactory system, the paralog SCGB1C1 is thought to ferry odorant molecules through mucus to odorant receptors (pmc.ncbi.nlm.nih.gov). By analogy, SCGB1C2 might ferry or neutralize bioactive compounds in the eye or reproductive tract, although direct experimental evidence is lacking. It is important to note that secretoglobins can also act as carrier proteins for pheromones or signaling lipids: in rodents, a large expansion of secretoglobin-like genes encodes androgen-binding proteins (ABPs) that carry pheromonal cues in saliva (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Humans have only a few counterparts of these ABPs. While SCGB1C2 is not formally classified as an ABP, its presence in testis could hint at a role in reproductive signaling or immune privilege. The testis is an immune-privileged site where controlling inflammation is crucial for sperm development; a secreted protein that binds inflammatory lipids or cytokines could be beneficial. Thus, one hypothesis is that SCGB1C2 contributes to maintaining an optimal extracellular environment in the testis and retina by binding potentially harmful or signaling molecules – a role analogous to known secretoglobins in other tissues.

In terms of pathway integration, SCGB1C2 is not known to be part of any canonical signaling pathway or metabolic chain (for example, it is not an enzyme in metabolism (www.proteinatlas.org)). Instead, its action is likely indirect: by binding ligands, it can modulate pathways such as olfactory signal transduction, retinoid recycling, or inflammatory signaling without being an enzyme or receptor itself. For instance, if SCGB1C2 binds a pro-inflammatory eicosanoid, it could dampen the activation of that eicosanoid’s receptor, effectively tweaking the immune signaling pathway in that locale. This mode of action is comparable to SCGB1A1, which by binding leukotriene D4 can inhibit leukotriene signaling and downstream inflammation (pmc.ncbi.nlm.nih.gov). Similarly, SCGB1C1 in olfactory mucus may present odorants to olfactory receptors, influencing the sensory transduction pathway (pmc.ncbi.nlm.nih.gov). For SCGB1C2, one might speculate involvement in the visual cycle or reproductive signaling, but no studies have confirmed such roles. It has not been shown to have receptor agonist or antagonist activity on its own; rather, any signaling impact would come from altering ligand distribution. There is also no evidence so far that SCGB1C2 forms heterodimers with other secretoglobins (as some family members do, e.g. mammaglobin A/SCGB2A2 dimerizes with lipophilin B/SCGB1D2 in breast tissue (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)). SCGB1C2 likely homodimerizes with itself given its unique expression profile separate from SCGB1C1.

Current Research and Clinical Insights: As of now, SCGB1C2 remains one of the less-characterized secretoglobins. A decade ago, only nine human SCGB genes had been functionally described (pmc.ncbi.nlm.nih.gov), but genomic analyses later brought that number to eleven, including SCGB1C2 (pmc.ncbi.nlm.nih.gov). The discovery of SCGB1C2 as a distinct gene (originally annotated as “SCGB1C1-like”) came through genome sequencing efforts rather than through targeted biochemical studies. The absence of a UniProtKB/Swiss-Prot functional summary for SCGB1C2 (as of 2025) underscores the gap in experimental data (www.genecards.org). However, large-scale omics projects have started to shed light on its expression. The Human Protein Atlas (updated 2022–2023) identified SCGB1C2 RNA in specific cell types, which is a crucial first step in pinpointing where the protein might act (www.proteinatlas.org). To date, no disease-causing mutations or major polymorphisms in SCGB1C2 have been reported in the literature. SCGB1C2 is not a prominent hit in genome-wide association studies, though one database (MalaCards) notes a tentative link to “inflammatory spondylopathy” (www.genecards.org). This association likely comes from high-throughput data and is not yet backed by mechanistic studies. In contrast, other secretoglobins have clearer clinical connections: for example, SCGB2A2 (Mammaglobin-A) is overexpressed in breast cancer and used as a tumor marker (pmc.ncbi.nlm.nih.gov), and SCGB1A1 levels in serum or sputum can serve as a biomarker for lung injury and inflammation (pmc.ncbi.nlm.nih.gov). No such clinical biomarker role has been established for SCGB1C2. Its restricted expression in pancreas, retina, and testis means any systemic effects would be limited. It’s worth noting that secretoglobins can sometimes be ectopically expressed in cancers – for instance, mammaglobins in gynecologic tumors (pmc.ncbi.nlm.nih.gov) – so researchers have examined SCGB gene expression across cancers. A broad tumor profiling study (Zafrakas et al. 2006) looked at mammaglobin and lipophilin family members in many tumors (pmc.ncbi.nlm.nih.gov), but SCGB1C2 was not highlighted, implying it was either not expressed or not tested in those contexts. In the pancreas, SCGB1C2’s presence raises the question of whether it plays a role in pancreatic diseases; however, common pancreatic conditions (like pancreatitis or pancreatic cancer) have not yet been linked to this gene in literature.

Expert Perspectives: Experts in the field have pointed out that further research is needed to elucidate SCGB1C2’s function. The secretoglobin family as a whole has drawn interest for its evolutionary diversification and unique roles in chemical communication and immunity (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In a 2011 family-wide analysis, Jackson et al. noted that mouse secretoglobins underwent an “evolutionary bloom” (with >60 related genes, many for pheromone binding), whereas humans have a much smaller repertoire (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The human SCGB1C subfamily (to which SCGB1C2 belongs) is thought to correspond to some of these chemical communication functions. Shioko Kimura, a leading researcher on secretoglobins, has described SCGB proteins like SCGB1A1 as “multi-functional cytokine-like molecules” that partake in intercellular signaling despite not being classical cytokines (pmc.ncbi.nlm.nih.gov). This view encourages investigating SCGB1C2 for any paracrine effects it might have on neighboring cells (for example, modulating immune cells in tissues). So far, no direct protein–protein interactions involving SCGB1C2 have been reported (as per databases, it has zero known protein interaction partners (www.proteinatlas.org) (www.proteinatlas.org)). This is expected for a secreted carrier protein, which would primarily interact with small molecules rather than large protein complexes. The lack of known interactions also suggests SCGB1C2 might exert its influence by chemical sequestration rather than by binding to a receptor or signaling complex. In line with this, no specific signaling pathway “node” is attributed to SCGB1C2 in Reactome or KEGG pathway databases (it is absent from metabolic pathway charts, consistent with a binding protein role (www.proteinatlas.org)).

In summary, SCGB1C2 is presumed to function as a secreted ligand-binding protein that contributes to local tissue homeostasis. Its protein product is secreted to the extracellular space, where it likely binds small hydrophobic substrates – by analogy, possibly odorants, lipids, or steroids – although the exact substrate specificity remains unknown. Through this ligand-binding activity, SCGB1C2 may regulate biochemical pathways indirectly: for example, buffering inflammatory mediators or facilitating the transport of chemical signals to receptors. It carries out its function in specific sites such as pancreatic secretions, the retinal interphotoreceptor matrix, or the seminiferous tubule fluid of the testes. These locations suggest roles in the ciliary/ocular environment and reproductive system, potentially guarding tissue integrity or influencing cell-cell signaling in those contexts. While broad pleiotropic effects have not been documented for SCGB1C2, understanding its precise role will likely require targeted studies (e.g. ligand binding assays or knockout models). The current understanding (as of 2023) is thus largely inferential: SCGB1C2 is part of a family known for dimeric secreted proteins that modulate inflammation and bind hydrophobic ligands, so it is expected to perform a similar biochemical role within the particular tissues where it is expressed (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). As one review succinctly stated, “the biological activities of most individual SCGBs have not been fully characterized” (pmc.ncbi.nlm.nih.gov) – a statement that certainly applies to SCGB1C2. Going forward, primary research – such as biochemical ligand screens or tissue-specific knockout studies – will be needed to definitively identify SCGB1C2’s substrates and physiological function. Such studies could elucidate whether SCGB1C2 has a niche role (for example, an odorant or retinoid-binding protein in a specialized compartment) or a broader immunomodulatory function akin to its secretoglobin relatives. Until then, SCGB1C2 remains an intriguing but under-characterized member of the secretoglobin family, known to be secreted and likely ligand-binding, with a presumed role in maintaining chemical balance in select human tissues (www.genecards.org) (pmc.ncbi.nlm.nih.gov).

References:

• Jackson BC et al. (2011). Human Genomics 5(6): 691–702. DOI: 10.1186/1479-7364-5-6-691. “Update of the human secretoglobin (SCGB) gene superfamily…” – Comprehensive review of the SCGB family (notes 11 human SCGB genes, secreted dimer structure, ligand binding) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).

• Lu X et al. (2011). Respiratory Research 12: 28. DOI: 10.1186/1465-9921-12-28. “Cytokine-driven regulation of secretoglobins in human airway…” – Investigates expression of several SCGBs (SCGB1C1, SCGB3A2, etc.) in airway; discusses SCGBs in immunity (SCGB1C1 = RYD5 in olfactory glands as odorant-binder) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).

• Kimura S et al. (2022). Pharmacology & Therapeutics 236: 108112. DOI: 10.1016/j.pharmthera.2022.108112. “Emerging role of an immunomodulatory protein Secretoglobin 3A2 in human diseases” – Review of SCGB3A2 and comparisons to SCGB1A1; highlights secretoglobins as cytokine-like, anti-inflammatory molecules in lung context (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).

• Human Protein Atlas (v23, 2023) – Protein expression database. Entry for SCGB1C2 (ENSG00000268320) shows tissue-enhanced RNA expression in pancreas and group-enriched expression in retinal Müller glia and testis spermatids; predicts SCGB1C2 is a locally secreted protein (www.proteinatlas.org) (www.proteinatlas.org).

• GeneCards (Updated Jul 17, 2025). “SCGB1C2 Gene – Secretoglobin Family 1C Member 2.” – Aggregated gene database. Confirms SCGB1C2 is a protein-coding gene on chr17, paralogous to SCGB1C1, and “predicted to be located in extracellular region” (Alliance Genome 2025) (www.genecards.org) (www.genecards.org).

• UniProt/InterPro Annotations – SCGB1C2 (UniProt P0DMR2) is annotated with secretoglobin domain signatures (Secretoglobin_1C-like), consistent with the secretoglobin fold and function (www.genecards.org).

• Zafrakas M et al. (2006). BMC Cancer 6: 88. DOI: 10.1186/1471-2407-6-88. – Expression analysis of mammaglobin (SCGB2A2) and lipophilin B (SCGB1D2) in tumors (pmc.ncbi.nlm.nih.gov). (While SCGB1C2 is not discussed, this study exemplifies how some SCGBs are co-expressed and used as cancer markers, highlighting the diverse roles of the family.)

Citations

1. AnnotationURLCitation(end_index=274, start_index=182, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=,3')
2. AnnotationURLCitation(end_index=474, start_index=342, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=SCGB1C2%20,of%20this%20gene%20is%20SCGB1C1')
3. AnnotationURLCitation(end_index=777, start_index=625, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20secretoglobins%20,discovered%20suggests%20that%20this%20family')
4. AnnotationURLCitation(end_index=922, start_index=778, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGBs%20are%20small%20%28,covalent%20interactions%20%5B%2018')
5. AnnotationURLCitation(end_index=1203, start_index=1080, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=SCGB1C2%20Gene%20,1C%20Member%202')
6. AnnotationURLCitation(end_index=1336, start_index=1204, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=NCBI%20Gene%20Summary%20for%20SCGB1C2,Gene')
7. AnnotationURLCitation(end_index=1773, start_index=1629, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGBs%20are%20small%20%28,covalent%20interactions%20%5B%2018')
8. AnnotationURLCitation(end_index=2024, start_index=1900, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=second%20reason%20was%20proposed%20for,3')
9. AnnotationURLCitation(end_index=2139, start_index=2025, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20uteroglobin%20,in%20each')
10. AnnotationURLCitation(end_index=2460, start_index=2336, title='Protein structure - SCGB1C2 - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2/structure%2Binteraction#:~:text=,PUBLICATIONS')
11. AnnotationURLCitation(end_index=2722, start_index=2578, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGBs%20are%20small%20%28,covalent%20interactions%20%5B%2018')
12. AnnotationURLCitation(end_index=3034, start_index=2875, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=structures%20of%20several%20SCGBs%20have,covalent%20interactions%20%5B%2018')
13. AnnotationURLCitation(end_index=3149, start_index=3035, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20uteroglobin%20,in%20each')
14. AnnotationURLCitation(end_index=3524, start_index=3410, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20uteroglobin%20,in%20each')
15. AnnotationURLCitation(end_index=3923, start_index=3803, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGB1C1%20has%20been%20shown%20to,25')
16. AnnotationURLCitation(end_index=4164, start_index=4044, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGB1C1%20has%20been%20shown%20to,25')
17. AnnotationURLCitation(end_index=4610, start_index=4426, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=Domains%20%26%20Families%20for%20SCGB1C2,like%20%2A%20Secretoglobin_sf%20%23%23%23%20Graphical')
18. AnnotationURLCitation(end_index=4922, start_index=4802, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGB1C1%20has%20been%20shown%20to,25')
19. AnnotationURLCitation(end_index=5037, start_index=4923, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20uteroglobin%20,in%20each')
20. AnnotationURLCitation(end_index=5518, start_index=5391, title='Emerging role of an immunomodulatory protein Secretoglobin 3A2 in human diseases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9271138/#:~:text=Leucine,that%20SCGB3A2%20belongs%20to%20the')
21. AnnotationURLCitation(end_index=6194, start_index=6051, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Extracellular%20location,Muller%20glia%20cells%2C%20Late')
22. AnnotationURLCitation(end_index=6423, start_index=6293, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Extracellular%20location,Cilium%20%28mainly')
23. AnnotationURLCitation(end_index=6775, start_index=6632, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Extracellular%20location,Muller%20glia%20cells%2C%20Late')
24. AnnotationURLCitation(end_index=6920, start_index=6776, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Single%20cell%20type%20specificity,Hemostasis%20%28mainly')
25. AnnotationURLCitation(end_index=7318, start_index=7159, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=TISSUE%20RNA%20EXPRESSION%20Tissue%20specificity,no%20cluster%20assigned')
26. AnnotationURLCitation(end_index=7720, start_index=7565, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=bloom%27%20and%20make%20up%20a,SCGBs%20in%20recent%20years%2C%20clearly')
27. AnnotationURLCitation(end_index=7876, start_index=7721, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=Secretoglobins%20are%20found%20at%20high,Some%20SCGB%20family%20members')
28. AnnotationURLCitation(end_index=8319, start_index=8205, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Gene%20name,i%7D%20Secreted')
29. AnnotationURLCitation(end_index=8677, start_index=8550, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Tissue%20profile,no%20cluster%20assigned')
30. AnnotationURLCitation(end_index=8963, start_index=8831, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=NCBI%20Gene%20Summary%20for%20SCGB1C2,Gene')
31. AnnotationURLCitation(end_index=9228, start_index=9078, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Tissue%20profile,Locally%20secreted%20TISSUE%20RNA%20EXPRESSION')
32. AnnotationURLCitation(end_index=10870, start_index=10706, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=including%20fluids%20of%20the%20lung%2C,Such%20information%20is%20predicted%20to')
33. AnnotationURLCitation(end_index=11033, start_index=10871, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=The%20pathophysiological%20functions%20of%20SCGBs,However%2C%20as%20to%20other')
34. AnnotationURLCitation(end_index=11460, start_index=11296, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=including%20fluids%20of%20the%20lung%2C,Such%20information%20is%20predicted%20to')
35. AnnotationURLCitation(end_index=11990, start_index=11876, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20uteroglobin%20,in%20each')
36. AnnotationURLCitation(end_index=12148, start_index=11991, title='Emerging role of an immunomodulatory protein Secretoglobin 3A2 in human diseases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9271138/#:~:text=cells%20that%20was%20the%20first,of%20actions%20and%20signaling%20pathway')
37. AnnotationURLCitation(end_index=12613, start_index=12456, title='Emerging role of an immunomodulatory protein Secretoglobin 3A2 in human diseases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9271138/#:~:text=cells%20that%20was%20the%20first,of%20actions%20and%20signaling%20pathway')
38. AnnotationURLCitation(end_index=12787, start_index=12614, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=The%20expression%20of%20SCGBs%20except,postoperative%20endoscopy%20and%20symptom%20scores')
39. AnnotationURLCitation(end_index=13909, start_index=13789, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGB1C1%20has%20been%20shown%20to,25')
40. AnnotationURLCitation(end_index=14494, start_index=14322, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=fully%20characterised%2C%20what%20already%20has,identify%20tissue%20damage%20or%20cancer')
41. AnnotationURLCitation(end_index=14633, start_index=14495, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=tumorigenesis,Such%20information%20is%20predicted%20to')
42. AnnotationURLCitation(end_index=15563, start_index=15439, title='Protein structure - SCGB1C2 - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2/structure%2Binteraction#:~:text=,PUBLICATIONS')
43. AnnotationURLCitation(end_index=16240, start_index=16126, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20uteroglobin%20,in%20each')
44. AnnotationURLCitation(end_index=16494, start_index=16374, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGB1C1%20has%20been%20shown%20to,25')
45. AnnotationURLCitation(end_index=17083, start_index=16994, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=1,doi')
46. AnnotationURLCitation(end_index=17172, start_index=17084, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=,doi')
47. AnnotationURLCitation(end_index=17594, start_index=17471, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=%5B1%20,as%20in%20the%20mammary%20gland')
48. AnnotationURLCitation(end_index=17824, start_index=17672, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20secretoglobins%20,discovered%20suggests%20that%20this%20family')
49. AnnotationURLCitation(end_index=18291, start_index=18127, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=No%20data%20available%20for%20CIViC,piRNA%20Summary%20for%20SCGB1C2%20Gene')
50. AnnotationURLCitation(end_index=18682, start_index=18539, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Extracellular%20location,Muller%20glia%20cells%2C%20Late')
51. AnnotationURLCitation(end_index=19084, start_index=18952, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=SCGB1C2%20,of%20this%20gene%20is%20SCGB1C1')
52. AnnotationURLCitation(end_index=19448, start_index=19359, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=1,doi')
53. AnnotationURLCitation(end_index=19712, start_index=19550, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=and%20SCGB3A2%20%28UGRP1%29%20%5B3%20,diseases%20has%20been%20rarely%20studied')
54. AnnotationURLCitation(end_index=20111, start_index=20022, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=1,doi')
55. AnnotationURLCitation(end_index=20389, start_index=20300, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=1,doi')
56. AnnotationURLCitation(end_index=21195, start_index=21023, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=fully%20characterised%2C%20what%20already%20has,identify%20tissue%20damage%20or%20cancer')
57. AnnotationURLCitation(end_index=21351, start_index=21196, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=Secretoglobins%20are%20found%20at%20high,Some%20SCGB%20family%20members')
58. AnnotationURLCitation(end_index=21720, start_index=21568, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20secretoglobins%20,discovered%20suggests%20that%20this%20family')
59. AnnotationURLCitation(end_index=21859, start_index=21721, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=tumorigenesis,identify%20tissue%20damage%20or%20cancer')
60. AnnotationURLCitation(end_index=22342, start_index=22215, title='Emerging role of an immunomodulatory protein Secretoglobin 3A2 in human diseases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9271138/#:~:text=Secretoglobin%20,This%20review%20summarizes')
61. AnnotationURLCitation(end_index=22810, start_index=22653, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Protein%20evidence%20Evidence%20at%20protein,i%7D%20Locally%20secreted')
62. AnnotationURLCitation(end_index=22966, start_index=22811, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Protein%20interactions%20No%20protein%20interactions,i%7D%20Secreted')
63. AnnotationURLCitation(end_index=23606, start_index=23482, title='Protein structure - SCGB1C2 - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2/structure%2Binteraction#:~:text=,PUBLICATIONS')
64. AnnotationURLCitation(end_index=25185, start_index=25021, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=including%20fluids%20of%20the%20lung%2C,Such%20information%20is%20predicted%20to')
65. AnnotationURLCitation(end_index=25306, start_index=25186, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGB1C1%20has%20been%20shown%20to,25')
66. AnnotationURLCitation(end_index=25582, start_index=25430, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20secretoglobins%20,discovered%20suggests%20that%20this%20family')
67. AnnotationURLCitation(end_index=26420, start_index=26288, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=NCBI%20Gene%20Summary%20for%20SCGB1C2,Gene')
68. AnnotationURLCitation(end_index=26583, start_index=26421, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=The%20pathophysiological%20functions%20of%20SCGBs,However%2C%20as%20to%20other')
69. AnnotationURLCitation(end_index=27026, start_index=26874, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=The%20secretoglobins%20,discovered%20suggests%20that%20this%20family')
70. AnnotationURLCitation(end_index=27171, start_index=27027, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGBs%20are%20small%20%28,covalent%20interactions%20%5B%2018')
71. AnnotationURLCitation(end_index=27609, start_index=27489, title="Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily - PMC", type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/#:~:text=SCGB1C1%20has%20been%20shown%20to,25')
72. AnnotationURLCitation(end_index=27772, start_index=27610, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=The%20pathophysiological%20functions%20of%20SCGBs,However%2C%20as%20to%20other')
73. AnnotationURLCitation(end_index=28235, start_index=28108, title='Emerging role of an immunomodulatory protein Secretoglobin 3A2 in human diseases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9271138/#:~:text=Secretoglobin%20,This%20review%20summarizes')
74. AnnotationURLCitation(end_index=28393, start_index=28236, title='Emerging role of an immunomodulatory protein Secretoglobin 3A2 in human diseases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9271138/#:~:text=cells%20that%20was%20the%20first,of%20actions%20and%20signaling%20pathway')
75. AnnotationURLCitation(end_index=28820, start_index=28677, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Extracellular%20location,Muller%20glia%20cells%2C%20Late')
76. AnnotationURLCitation(end_index=28965, start_index=28821, title='SCGB1C2 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000268320-SCGB1C2#:~:text=Single%20cell%20type%20specificity,Hemostasis%20%28mainly')
77. AnnotationURLCitation(end_index=29364, start_index=29241, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=SCGB1C2%20Gene%20,1C%20Member%202')
78. AnnotationURLCitation(end_index=29497, start_index=29365, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=NCBI%20Gene%20Summary%20for%20SCGB1C2,Gene')
79. AnnotationURLCitation(end_index=29873, start_index=29689, title='SCGB1C2 Gene - GeneCards | SG1C2 Protein | SG1C2 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2#:~:text=Domains%20%26%20Families%20for%20SCGB1C2,like%20%2A%20Secretoglobin_sf%20%23%23%23%20Graphical')
80. AnnotationURLCitation(end_index=30132, start_index=30043, title='The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/#:~:text=1,doi')

The SCGB1C2 (P0DMR2) gene encodes the protein Secretoglobin family 1C member 2, a small, secreted protein in the secretoglobin superfamily. Current research indicates its primary molecular function is as a secreted regulatory protein, with emerging evidence for roles in immune modulation and disease association.

1. Key Concepts and Definitions

• Gene Name: SCGB1C2 (Secretoglobin Family 1C Member 2)
• Protein ID: UniProt P0DMR2
• Gene Family: Secretoglobins (SCGB), a family of small, secreted proteins found exclusively in mammals[1][3][5].

2. Molecular Function

• Primary Function: The precise molecular function of SCGB1C2 remains incompletely characterized. However, secretoglobins are generally involved in immune modulation, anti-inflammatory activity, and regulation of cell signaling[1].
• Recent Evidence: SCGB1C2 has been implicated as a critical regulatory factor during early viral infection, suggesting a role in host defense mechanisms[3].
• Gene Ontology (GO): The protein is annotated with functions related to extracellular region localization and protein binding, but specific molecular activities (e.g., enzymatic or receptor activity) have not been conclusively demonstrated[6][7][8].

3. Biological Processes

• Immune Response: Secretoglobins, including SCGB1C2, are thought to participate in immune regulation and anti-inflammatory processes[1].
• Disease Biomarker Potential: Some secretoglobins are up- or downregulated in various cancers and inflammatory conditions, suggesting a role in tumorigenesis and immune-related diseases[1][5].
• Knockout Phenotypes: Mouse knockout studies (IMPC) suggest that loss of SCGB1C2 may affect immune and inflammatory phenotypes, though detailed phenotypic data are limited[3].

4. Cellular Localization

• Extracellular/Secreted: SCGB1C2 is predicted and observed to be secreted into the extracellular region, consistent with other secretoglobins[5][8][9][10].
• Tissue Expression: Expression data indicate tissue-specific expression patterns, but detailed tissue distribution in humans is not fully mapped[11].

5. Protein Domains

• Secretoglobin Domain: The protein contains a secretoglobin domain, characteristic of the family, which typically forms small, stable, disulfide-linked dimers[8].
• Structure: Secretoglobins generally have a compact, alpha-helical structure, but no high-resolution structure for SCGB1C2 is currently available[8].

6. Known Interactions

• Protein-Protein Interactions: Direct interaction partners for SCGB1C2 have not been well characterized. Other secretoglobins are known to form homo- or heterodimers and may interact with immune system components[1].
• Functional Associations: Co-expression and functional association data suggest links to immune cell types and inflammatory pathways, but specific binding partners are not yet identified[3].

7. Disease Associations

• Inflammatory Spondylopathy: SCGB1C2 has been associated with inflammatory spondylopathy, though the mechanism is unclear[5].
• Cancer: Other secretoglobins are established biomarkers in cancers (e.g., breast, ovarian), but direct evidence for SCGB1C2 as a cancer biomarker is limited. Its paralog SCGB1C1 and related family members are more extensively studied in this context[1][5].
• Autoimmunity: There is emerging interest in secretoglobins as autoantigens, but no direct evidence links SCGB1C2 to specific autoimmune diseases[2].

8. Recent Developments and Research (2023–2024)

• Gene Expression Profiling: Recent datasets (GTEx, Tabula Sapiens) are being used to map SCGB1C2 expression across tissues and cell types, with ongoing efforts to clarify its physiological roles[3][11].
• Functional Genomics: Ongoing knockout and association studies are expected to further elucidate the biological significance of SCGB1C2 in immune regulation and disease[3].

9. Expert Opinions and Analysis

• Current Consensus: SCGB1C2 is recognized as a member of a functionally important but understudied protein family with likely roles in immune modulation and extracellular signaling[1][5].
• Research Gaps: There is a need for more detailed functional studies, including identification of interaction partners, structural analysis, and disease mechanism elucidation[1][8].

10. Relevant Statistics and Data

• Gene ID: NCBI Gene 653486
• UniProt Accession: P0DMR2
• Expression: Detected in extracellular regions; tissue-specific expression patterns under investigation[5][8][11].

URLs and Publication Dates

• GeneCards SCGB1C2 (2025)[5]
• UniProt P0DMR2 (2024)[8]
• Harmonizome SCGB1C2 (2023)[3]
• NIH PMC Secretoglobin Review (2012, still authoritative for family context)[1]
• Open Targets SCGB1C2 (2024)[9]
• Human Protein Atlas SCGB1C2 (2024)[11]

In summary: SCGB1C2 encodes a secreted protein of the secretoglobin family, likely involved in immune regulation and extracellular signaling, with emerging but still limited evidence for disease associations and molecular interactions. Further research is needed to clarify its precise biological functions and clinical relevance.

Citations

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/
2. https://patents.google.com/patent/US20230357754A1/en
3. https://maayanlab.cloud/Harmonizome/gene/SCGB1C2
4. https://digitalcommons.usf.edu/context/etd/article/8104/viewcontent/Mohamed_usf_0206D_14282.pdf
5. https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2
6. https://functionome.geneontology.org/gene/UniProtKB:P0DMR2
7. https://amigo.geneontology.org/amigo/gene_product/UniProtKB:P0DMR2
8. https://www.uniprot.org/uniprot/P0DMR2-1
9. https://platform.opentargets.org/target/ENSG00000268320?from=genetics
10. http://biogps.org/gene/653486/
11. https://www.proteinatlas.org/ENSG00000268320-SCGB1C2/tissue

SCGB1C2 (Secretoglobin Family 1C Member 2): A Comprehensive Functional and Molecular Analysis

SCGB1C2, known as secretoglobin family 1C member 2 and encoded by the gene located at genomic position ENSG00000268320, represents an understudied member of the secretoglobin protein superfamily with emerging evidence suggesting critical roles in viral immune response and inflammatory regulation. This protein, designated with UniProtKB accession P0DMR2 and commonly referred to as SG1C2_HUMAN, has recently garnered attention as a regulatory factor with potential therapeutic applications in antiviral strategies and immunodeficiency management. Recent evidence indicates that SCGB1C2 functions as a critical regulatory factor during early viral infection, underscoring its integrative function as a potential therapeutic target in both antiviral strategies and the treatment of immunodeficiency disorders.[1][10][14][23] Despite these promising leads, SCGB1C2 remains less comprehensively characterized than other secretoglobin family members, necessitating a synthesis of structural bioinformatics, evolutionary comparisons, and the limited functional data currently available to construct a coherent understanding of its biological role.

The Secretoglobin Protein Family: Structural Context and Classification

Defining Characteristics of Secretoglobins

Secretoglobins (SCGBs) represent a distinctive mammalian protein family characterized by several defining structural and functional properties that distinguish them from other secreted proteins. Secretoglobins are small, alpha-helical, disulfide-linked, dimeric proteins found exclusively in mammals, a characteristic that underscores their evolutionary specialization within the mammalian proteome.[8][50] These proteins typically achieve a molecular weight of approximately ten kilodaltons in their mature, processed form, making them among the smallest members of the secreted protein repertoire.[26][33][52] The fundamental structural architecture consists of predominantly alpha-helical components arranged in an antiparallel configuration, with the dimeric interface forming through an intricate series of covalent disulfide bonds alongside non-covalent interactions.[33][52] This dimer configuration creates a distinctive feature unique among many protein families: an internal hydrophobic cavity positioned at the interface between the two monomeric subunits.[8][50] This cavity accommodates small to medium-sized lipophilic ligands, including steroid hormones, phospholipids, polychlorinated biphenyls, and various eicosanoid mediators of inflammation, providing a structural basis for their regulatory functions.[8][33][50]

A particularly notable characteristic of secretoglobin biology involves the coupling between ligand binding and the redox state of cysteine residues. The disulfide bonds that maintain the dimeric structure and create the ligand-binding cavity can undergo dynamic redox cycling, potentially allowing the binding and release of ligands to be coupled with the cellular redox environment.[8][50] This coupling mechanism suggests that secretoglobin function may be regulated not merely by protein expression levels or localization, but also by the local oxidizing or reducing conditions encountered by these proteins during their secretion and extracellular function. Such redox-dependent regulation would allow secretoglobins to serve as environmental sensors, modulating their activity in response to oxidative stress conditions that often accompany inflammation and infection.

Classification and Evolutionary Organization of Secretoglobin Subfamilies

The secretoglobin family underwent systematic classification in 2006 through sequence homology analysis, resulting in the designation of six subfamilies.[50] However, subsequent comprehensive genomic analysis in 2011 revealed that the human and mouse genomes contain only the first three of these originally proposed subfamilies, with subfamily four and six subsequently recognized as duplicates of existing groups, and subfamily five absent from both major mammalian genomes.[50][52] This refined understanding of secretoglobin organization has important implications for understanding SCGB1C2, as it belongs to subfamily 1C, which includes both SCGB1C1 and SCGB1C2 as distinct members.[50] The broader subfamily 1 designation encompasses multiple groups including the foundational SCGB1A1 (also known as uteroglobin, Clara cell protein, or CCSP), the ABPA-like group, the SCGB1C group containing SCGB1C2, and the lipophilin group.[8][50]

The evolutionary relationships within the secretoglobin family reveal important context for understanding SCGB1C2. The human genome contains eleven SCGB genes along with five pseudogenes, whereas the mouse genome harbors approximately sixty-eight SCGB genes, including several examples of what researchers term "evolutionary blooms"—independent expansions of specific SCGB subfamilies in particular mammalian lineages.[33][52] This expansion pattern suggests differential selective pressures on secretoglobin genes across different mammalian species, likely reflecting species-specific adaptations in immune regulation and barrier organ function. The relatively restricted number of SCGB genes in humans compared to rodents may reflect the increased complexity of human immune regulation achieved through more refined signaling mechanisms rather than gene duplication.

SCGB1C2 Gene and Protein Identity: Genomic and Molecular Characteristics

Genomic Organization and Gene Designation

SCGB1C2 is a protein-coding gene located on the human genome with systematic identifiers ENSG00000268320 (Ensembl), NCBI Gene ID 653486, and HGNC 51242.[1][2][4][30][34] The gene belongs to the broader secretoglobin family classification, with the official nomenclature designating it as the second member of the 1C subfamily.[1][4][10] Like other members of the secretoglobin family, the SCGB1C2 gene maintains the characteristic three-exon structure typical of all SCGB family genes, though detailed information regarding specific exon sizes, intron sequences, and regulatory elements remains limited in publicly available databases.[33] The gene is located on human chromosome 11, placing it in proximity to other SCGB genes and potentially within a conserved gene cluster.[4] The protein product is designated with the UniProtKB identifier P0DMR2 and is referred to in proteomic databases as SG1C2_HUMAN.[1][2][4][5]

Protein Structure and Processing

The primary translation product of SCGB1C2 contains an amino-terminal signal peptide approximately twenty residues in length, characteristic of all secretoglobin family members and essential for directing the nascent polypeptide chain to the endoplasmic reticulum.[38] Signal peptidase cleavage during translocation into the endoplasmic reticulum lumen removes this signal peptide, producing the mature protein with an approximate molecular weight of six kilodaltons as a monomer, consistent with typical secretoglobin architecture.[26][33] The mature protein subsequently undergoes dimerization through formation of disulfide bonds and non-covalent interactions, creating a stable homodimeric complex of approximately twelve kilodaltons.[26][33] This dimeric form represents the predominant functional unit for secretoglobin proteins in extracellular spaces.

Like other secretoglobin family members, SCGB1C2 likely contains the characteristic cysteine residues essential for both disulfide bond formation maintaining dimer stability and the creation of the internal hydrophobic cavity.[33] The complete amino acid sequence and precise identification of functionally critical residues await detailed crystallographic analysis; however, sequence homology with other secretoglobin family members provides strong evidence for the conservation of four alpha-helical domains arranged in the characteristic secretoglobin architecture.[8][50] The presence of hydrophobic residues capable of forming the ligand-binding pocket can be inferred from structural homology with characterized secretoglobin proteins like SCGB1A1 and SCGB3A2, though direct biochemical confirmation remains lacking for SCGB1C2 specifically.

Cellular Localization and Tissue Distribution

Extracellular Localization and Compartmentalization

Bioinformatic prediction algorithms consistently predict SCGB1C2 to be located in the extracellular region, a designation confirmed by multiple sequence analysis tools that recognize the signal peptide directing the protein to the secretory pathway.[4][11][30][34][40] This predicted localization aligns perfectly with the broader characteristics of the secretoglobin family, as all members are secreted proteins functioning in extracellular spaces rather than intracellular compartments. The pathway for SCGB1C2 secretion follows the classical secretory route: co-translational translocation through the endoplasmic reticulum via signal recognition particle recognition, transport through the Golgi apparatus, and eventual secretion via secretory vesicles into the extracellular space.[38] The signal peptide-dependent targeting ensures that SCGB1C2 cannot accumulate in the cytosol or other intracellular compartments, but rather must function exclusively at epithelial surfaces, in mucus layers, or in other extracellular compartments appropriate to its physiological roles.

Tissue and Cellular Expression Patterns

Gene expression data available through databases indicates that SCGB1C2 exhibits a broad but selective tissue distribution pattern. The protein is expressed in monocytes, granulocytes, and the olfactory segment of nasal mucosa, along with numerous other cell types and tissues totaling at least sixty-four distinct cell types or tissues displaying SCGB1C2 expression.[40][46] This pattern of widespread but controlled expression suggests roles in immune regulation and barrier organ function rather than tissue-specific specialization. The presence of SCGB1C2 in both immune cells (monocytes and granulocytes) and epithelial tissues suggests a dual role in coordinating immune responses and regulating local inflammatory processes at barrier sites. Recent single-cell RNA sequencing data indicates expression in ciliated respiratory epithelial cells, basal respiratory cells, and club cells, consistent with roles in airway immune regulation.[46] Club cells, also known as Clara cells or secretory cells in the terminal bronchioles, represent a primary secretory cell type in the respiratory epithelium and known producers of various SCGB family proteins; the expression of SCGB1C2 in these cells suggests roles in airway immunoregulation.[43][46]

The expression in the olfactory segment of nasal mucosa is particularly intriguing, as this specialized tissue represents a unique site of immune interface between the external environment and the central nervous system, suggesting SCGB1C2 may participate in protective immune mechanisms at this vulnerable location.[40] Additionally, the broad expression across immune cell types including monocytes and granulocytes indicates roles in innate immune regulation. This distribution pattern contrasts with some other secretoglobin family members like SCGB2A2 (mammaglobin-A), which demonstrates highly tissue-specific expression restricted to breast epithelium, suggesting SCGB1C2 may have more broadly distributed immune regulatory functions.[33][52]

Disease Associations and Clinical Significance

Inflammatory Spondylopathy Association

The primary disease association identified for SCGB1C2 in current databases is inflammatory spondylopathy, a group of inflammatory conditions affecting the spine and vertebral joints, characterized by inflammatory infiltration and structural remodeling of spinal tissues.[4][30][34][59] This association appears consistently across multiple curated disease databases and has been derived through text mining of biomedical literature, manually curated annotations, and genome-wide association studies.[59] Inflammatory spondylopathy encompasses conditions including ankylosing spondylitis and related disorders, characterized by activation of innate immune responses and systemic inflammation affecting spinal joints and entheses. The mechanistic basis for SCGB1C2 involvement in inflammatory spondylopathy pathogenesis remains to be elucidated; however, several plausible mechanisms exist. Given the demonstrated role of other secretoglobin family members in anti-inflammatory processes and immune regulation, SCGB1C2 dysfunction or altered expression might contribute to exaggerated inflammatory responses characteristic of spondylopathy. Alternatively, altered SCGB1C2 expression might reflect changes in barrier function at sites involved in immune tolerance, allowing increased pathogenic immune responses.

The association with inflammatory spondylopathy is particularly noteworthy in light of the gene's close paralog, SCGB1C1, which shares the same disease association.[53][56] The parallel disease associations in two closely related secretoglobin family members suggest that the SCGB1C subfamily may possess specialized functions in regulating the inflammatory responses relevant to spondylopathy pathogenesis. Both SCGB1C1 and SCGB1C2 are predicted to be located in extracellular regions and likely share significant functional overlap despite their distinct gene products. This raises the possibility of redundant or compensatory functions within the SCGB1C subfamily, whereby dysfunction in one member might be partially compensated by the other, or conversely, coordinated dysregulation of both might be required for disease manifestation.

Function as a Viral Response Regulator

Critical Role in Early Viral Infection

Recent emerging evidence indicates that SCGB1C2 functions as a critical regulatory factor during early viral infection, representing one of the most substantive functional insights available for this protein.[1][10][14][23] This role as a viral response regulator places SCGB1C2 at an important intersection between innate immune recognition and the initiation of antiviral defense mechanisms. The designation as a "regulatory factor" suggests that SCGB1C2 does not directly combat viral replication through enzymatic activity but rather modulates the immune response to viral infection, potentially by enhancing or restraining specific branches of the innate immune cascade. The emphasis on "early" viral infection is particularly significant, as early innate immune responses determine the trajectory of subsequent adaptive immunity and either facilitate viral clearance or allow viral amplification depending on the adequacy of initial responses.[22][55]

The integrative function of SCGB1C2 in antiviral immunity relates to its potential as a therapeutic target in antiviral strategies.[23] This therapeutic potential likely stems from the capacity of SCGB1C2 to enhance protective antiviral responses through mechanisms that remain to be characterized. One plausible mechanism involves the regulation of type I interferon responses, which represent the primary antiviral defense mechanism initiated by pattern recognition receptor activation upon viral detection.[19][22][55] Impaired type I interferon responses have been associated with severe viral infections, including severe COVID-19, where deficient interferon-beta production and diminished interferon-stimulated gene expression correlate with high viral loads and excessive inflammation.[19][22] If SCGB1C2 functions to enhance or maintain type I interferon production or signaling, its upregulation could theoretically improve antiviral defense. Alternatively, SCGB1C2 might function in limiting excessive inflammation during viral infection, preventing the destructive inflammatory responses that can cause immunopathology while maintaining sufficient antiviral immunity.

Relationship to Type I Interferon Signaling

The innate immune response to viral infection proceeds through a well-characterized cascade of pattern recognition receptor activation, adaptor protein recruitment, kinase activation, and ultimately transcription factor engagement leading to interferon production.[22][55] Innate immune sensors including toll-like receptors (TLRs) and retinoic acid-inducible gene I (RIG-I)-like receptors recognize viral pathogen-associated molecular patterns (PAMPs) and initiate signaling through adaptor proteins including TRIF (TIR-domain-containing adapter-inducing interferon-beta), MyD88 (myeloid differentiation factor 88), and MAVS (mammalian mitochondrial antiviral signaling protein).[22][55] These adaptor proteins recruit and activate TANK-binding kinase 1 (TBK1), leading to phosphorylation and activation of interferon regulatory factors 3 and 7 (IRF3 and IRF7).[22][55] The activated transcription factors then drive the transcription of type I interferon genes (particularly IFN-beta and IFN-alpha genes) and numerous interferon-stimulated genes whose protein products collectively establish an antiviral state.[22][55]

The specific mechanisms through which SCGB1C2 participates in this cascade remain speculative without direct biochemical evidence. However, several possible roles warrant consideration. First, SCGB1C2 might function as a lipid ligand transporter or presenter similar to other secretoglobin family members, potentially delivering lipid mediators such as eicosanoids that modulate interferon signaling or enhance the transcription of interferon genes.[33][50][52] Some eicosanoids have immunomodulatory properties affecting interferon production and T cell differentiation, suggesting SCGB1C2 might concentrate these mediators at epithelial surfaces or within immune cell microenvironments to enhance antiviral responses.[7][36][57][58] Second, SCGB1C2 might directly interact with interferon signaling molecules or their receptors, potentially enhancing ligand-receptor interactions or preventing negative regulation of interferon signaling. Third, SCGB1C2 might function in regulating the maturation or function of immune cells responsible for interferon production, such as dendritic cells or plasmacytoid dendritic cells, which represent the major sources of type I interferon in response to viral infection.[22][55]

Immunoregulatory Functions and Mechanisms

Anti-inflammatory and Immune-Modulating Activities

While direct evidence for SCGB1C2 functions remains limited, considerable insight can be derived from the well-characterized functions of related secretoglobin family members, particularly the close paralog SCGB1C1 and the extensively studied SCGB1A1. These family members demonstrate that secretoglobins possess potent anti-inflammatory and immunomodulatory activities that influence various respiratory and systemic diseases.[7][36][57][58] SCGB1A1, the founding member and most extensively characterized secretoglobin, suppresses inflammation through multiple mechanisms including inhibition of phospholipase A2 activity, suppression of interferon-gamma signaling, and regulation of immune cell infiltration and function.[7][33][43][45][52][58] SCGB1A1 has been demonstrated to inhibit phospholipase A2 in vitro, a key enzyme responsible for the release of arachidonic acid from phospholipid bilayers, which undergoes subsequent oxidation to generate pro-inflammatory eicosanoid mediators.[43][45] By limiting phospholipase A2 activity, secretoglobins can reduce the generation of inflammatory lipid mediators, thereby providing an endogenous brake on inflammatory responses.

The closely related paralog SCGB1C1, which shares subfamily identity with SCGB1C2, exhibits particularly relevant functions for understanding potential SCGB1C2 biology. SCGB1C1 is notably expressed in the mucosa of the human respiratory tract and demonstrates responsiveness to cytokine signals, with its expression being downregulated by interferon-gamma (IFN-gamma), a prototypical Th1 cytokine, while simultaneously being upregulated by interleukins 4 and 13 (IL-4 and IL-13), prototypical Th2 cytokines.[9] This cytokine-driven regulation places SCGB1C1 at a critical junction in Th1/Th2 immune balance, suggesting that SCGB1C1 expression levels reflect and potentially modulate the dominant immune response type within the respiratory epithelium.[9] SCGB1C1 protein can modulate inflammation processes by binding steroid ligands, resulting in functional consequences including prevention of nasal polyp development.[9] This steroid binding capacity provides a specific mechanism through which secretoglobins might regulate inflammatory responses by sequestering and presenting glucocorticoid hormones to target cells.

Th1 and Th2 Immune Response Integration

The secretoglobin family demonstrates embedding within both Th1 and Th2 immune response pathways, a characteristic that underscores their importance in balancing protective immunity with appropriate inflammatory control.[7][36][58] Th1 responses, typically mediated by interferon-gamma production, promote cell-mediated immunity and defensive responses against intracellular pathogens, whereas Th2 responses, mediated by interleukins 4, 5, and 13, promote antibody-mediated immunity and regulation of certain inflammatory processes.[7][58] The differential regulation of specific secretoglobin family members by Th1 versus Th2 cytokines indicates that secretoglobins might serve as adjustable rheostat mechanisms for balancing these divergent immune response types. For instance, SCGB3A2 (also known as UGRP1), another well-characterized secretoglobin family member, demonstrates upregulation by Th1 cytokines (including IFN-gamma, as demonstrated through in vitro experiments with recombinant interferon-gamma), while simultaneously showing suppression by pro-inflammatory cytokines and Th2 cytokines.[20][32]

The expression of secretoglobins in a manner dependent on cell maturation represents an additional layer of immune regulation, suggesting that secretoglobin levels might reflect the developmental stage and differentiation state of epithelial cells and immune cells.[7][36] As epithelial cells mature and differentiate within airway tissues, their expression of various secretoglobin family members changes, potentially altering the local immunoregulatory environment to reflect the functional requirements of differently differentiated cell states. In developing lung tissue, distinct spatiotemporal expression patterns of SCGB1A1, SCGB3A1, and SCGB3A2 become apparent, with SCGB3A2 demonstrating the earliest expression beginning at embryonic day 14.5, followed by SCGB1A1 at embryonic day 16.5, and SCGB3A1 showing more restricted expression in larger airways.[21] These differential developmental expression patterns suggest specialized roles for different secretoglobin family members in regulating distinct aspects of lung development and the establishment of airway immunity.

Ligand Binding and Molecular Interactions

Structural Basis for Ligand Accommodation

The central hydrophobic cavity formed at the dimer interface of secretoglobin proteins creates a binding site capable of accommodating small to medium-sized lipophilic ligands, a characteristic that defines an important functional dimension of secretoglobin biology.[8][33][50] This cavity can bind steroid hormones, phospholipids, polychlorinated biphenyls, retinoids, and various eicosanoid mediators of inflammation.[8][33][50] The binding specificity and affinity for different ligand classes varies among secretoglobin family members, likely reflecting subtle differences in cavity geometry and amino acid composition within the binding pocket. For example, detailed studies of the feline secretoglobin Fel d 1, which shares structural homology with mammalian secretoglobins, revealed that fatty acids such as lauric acid bind within the internal/central cavity with good affinity (Kd of 2.6 micrometers), while steroid hormones like androstenone preferentially bind in surface cavities with distinct binding affinity (Kd of 2.4 micrometers).[49]

These binding interactions suggest that SCGB1C2, sharing the fundamental secretoglobin architecture, likely possesses similar capacity for lipophilic ligand binding. The functional consequence of this ligand binding capacity extends beyond simple molecular sequestration; rather, secretoglobins appear to function as specialized carriers that present bound ligands to specific cellular receptors or target molecules in extracellular spaces. For instance, the binding of eicosanoid mediators by secretoglobins may concentrate these potent inflammatory signaling molecules in specific microenvironments where they can exert maximal effect, or conversely, may sequester them away from inappropriate targets where they would cause excessive inflammation. Similarly, steroid hormone binding by secretoglobins may facilitate delivery of these signals to appropriate target cells while limiting non-specific dissemination throughout tissues.

Disulfide Bond-Dependent Regulation

A particularly intriguing aspect of secretoglobin function involves the coupling of ligand binding and release to the redox state of cysteine residues and the associated disulfide bonds.[8][50] The four cysteine residues typically present in secretoglobin proteins form one to three covalent disulfide bonds that maintain dimer stability and help create the ligand-binding cavity.[33] The oxidation state of these cysteines and the presence or absence of disulfide bonds can undergo dynamic interconversion under different redox conditions, suggesting that secretoglobin function might be regulated by the local cellular or tissue redox state.[8][50] In contexts where oxidative stress increases the local concentration of reactive oxygen species, secretoglobin disulfide bonds might undergo enhanced formation or resistance to reduction, maintaining stable dimeric configuration. Conversely, in reducing environments or during times of elevated reducing agent concentrations, disulfide bonds might undergo reduction, potentially destabilizing dimers or altering cavity geometry in ways that modify ligand binding properties.

This redox-dependent regulation provides a plausible mechanism through which secretoglobins could sense and respond to inflammatory microenvironments, where oxidative stress typically accompanies pathogenic immune responses and tissue damage. During viral infections, the innate immune response generates substantial oxidative stress as part of the antimicrobial arsenal employed by phagocytic cells and activated lymphocytes. If SCGB1C2 function or stability is sensitive to this oxidative stress, its activity might be dynamically modulated in response to infection severity, providing negative feedback to prevent excessive inflammatory damage while maintaining sufficient antiviral immunity.

Comparative Analysis with Related Secretoglobin Family Members

SCGB1C1 Paralog Relationships and Functional Considerations

SCGB1C2 shares its closest phylogenetic relationship with SCGB1C1, its paralog within the SCGB1C subfamily, and both genes are found on human chromosome 11, potentially suggesting recent evolutionary divergence from a common ancestral gene.[4][30][34][53][54][56] Both proteins possess identical disease associations with inflammatory spondylopathy, suggesting either overlapping functional roles in the pathogenesis of this disease or compensatory relationships whereby dysfunction in both proteins together contributes to disease.[4][30][34][53][54][59] The conservation of disease association across paralogous proteins suggests that the biological pathways disrupted in inflammatory spondylopathy involve functions relevant to both SCGB1C1 and SCGB1C2, whether through redundant roles or through complementary functions in coordinated processes.

SCGB1C1's well-documented responsiveness to specific cytokines—downregulation by IFN-gamma and upregulation by IL-4 and IL-13—provides a framework for predicting potential SCGB1C2 regulation, though direct evidence for similar cytokine responsiveness of SCGB1C2 remains lacking.[9] If SCGB1C2 demonstrates similar cytokine regulation, this would suggest coordinated control of the SCGB1C subfamily by the adaptive immune system, with Th1 responses suppressing SCGB1C family member expression while Th2 responses enhance it. This divergent regulation would position the SCGB1C subfamily as adaptive immune response integrators that adjust epithelial barrier immunoregulation based on the dominant T cell response type. The shared structural architecture and putative binding capabilities for steroid ligands between SCGB1C1 and SCGB1C2 suggest similar mechanisms of ligand-dependent immunoregulation, though subtle differences in binding pocket composition might confer distinct ligand specificities or binding affinities.

Comparison with SCGB1A1 and Broader Family Function

SCGB1A1 (uteroglobin, Clara cell protein), the founding and most extensively characterized secretoglobin family member, provides important context for understanding SCGB1C2 through functional and evolutionary perspectives. SCGB1A1 is abundantly present in peripheral airway surface fluid, representing one of the most abundant proteins in this important immune interface.[33][45][52] SCGB1A1 plays multiple roles including immunomodulation through regulation of cell infiltration, tissue repair after injury, and potentially anti-tumorigenic activity through suppression of cancer cell proliferation and invasion.[33][45][52] Studies of SCGB1A1-deficient mice indicate that this protein provides protection from oxidative stress, exerts anti-inflammatory actions, and provides resistance to pollutant-induced injury.[33] Notably, SCGB1A1 is initially downregulated to allow the body to respond to infection, suggesting a potential mechanism of immune suppression that must be overcome for effective immune responses to proceed.[33]

The more restricted expression pattern and potential more specialized functions of SCGB1C2 compared to the ubiquitously abundant SCGB1A1 suggest that SCGB1C2 might serve more specialized roles in immune regulation, potentially focused on specific immune contexts such as viral defense or specific tissue microenvironments. The broad distribution of SCGB1C2 expression across multiple cell types and tissues, while less ubiquitous than SCGB1A1, still suggests participation in general immune regulation rather than tissue-specific specialization. The emphasis on SCGB1C2 function during viral infection represents a functional distinction from SCGB1A1, which demonstrates downregulation during infection, suggesting SCGB1C2 might play complementary roles that remain upregulated or are enhanced during viral infection despite potential suppression of other secretoglobin family members.

Structural Considerations from Evolutionary and Bioinformatic Analysis

Phylogenetic Conservation and Evolutionary Insights

The preservation of SCGB1C2 in the mammalian genome, despite the noted selective pressures that have generated substantial variation in secretoglobin gene numbers across species, suggests that SCGB1C2 encodes a functionally important protein essential for core mammalian physiology or immune defense.[33][51][52] The evolutionary relationship between human and mouse orthologs, while not explicitly detailed in available literature, likely reveals through comparative genomic analysis that mammalian genes generally evolve more slowly than previously appreciated, with median substitution rates of approximately 0.32 substitutions per site per 10^9 years in rodent-human orthologous comparisons.[51] The conservation of SCGB1C2 across diverse mammalian species suggests that the functional role served by this protein remained important throughout mammalian evolution, resisting selective pressures that might have eliminated unnecessary genes.

The presence of pseudogenes related to secretoglobin genes in the human genome, with five pseudogenes accompanying eleven functional SCGB genes, suggests recent evolutionary history of gene duplication and divergence within the secretoglobin family.[33][52] If SCGB1C2 exists as a distinct functional gene without associated pseudogenes (as apparent from current annotations), this indicates successful preservation through evolution of a functional secretoglobin member that maintains enzymatic or regulatory functions important for species fitness. The evolutionary bloom phenomenon observed in rodent Scgb genes, where certain subfamilies expanded dramatically in specific species, contrasts with the more constrained secretoglobin repertoire in humans, potentially reflecting the greater reliance of humans on more sophisticated signaling mechanisms rather than on gene duplication for achieving immune complexity.[33][52]

Structural Homology and Functional Predictions

The conservation of the secretoglobin protein fold across family members, characterized by four alpha-helical domains forming an antiparallel homodimer with covalent disulfide bonds and a central hydrophobic cavity, provides strong structural evidence that SCGB1C2 maintains this fundamental architecture.[8][33][50][52] This structural conservation despite sequence divergence between family members suggests that the basic structural scaffold has proven functionally optimized for small lipophilic ligand binding and immune regulation across diverse biological contexts. The critical residues identified in SCGB1A1 (specifically Phe6, Leu13, Tyr21, Phe28, Met41, and Ile63), particularly the aromatic residues Phe6 and Tyr21 which cannot be replaced by aliphatic amino acids without loss of function, likely have structural homologs in SCGB1C2 based on sequence homology, suggesting similar ligand-binding requirements.[52]

The prediction of SCGB1C2 location in the extracellular region, derived from signal peptide recognition algorithms, represents a bioinformatic inference supported by the documented signal peptide characteristics of all secretoglobin family members. The successful prediction of secretory pathway targeting for protein members of a well-characterized family provides strong confidence in the localization prediction, as the signal peptide sequences of secretoglobin proteins exhibit sufficient conservation to be reliably recognized by multiple independent prediction algorithms. This localization prediction, combined with structural homology to characterized secretoglobin proteins, indicates that SCGB1C2 likely functions in extracellular compartments where barrier immunity occurs, including airway epithelial surfaces, mucosal tissues, and other sites of external environmental interface.

Conclusion and Future Directions

Synthesis of Current Knowledge

SCGB1C2 represents a member of the secretoglobin protein family that shares fundamental structural characteristics with its better-characterized relatives while maintaining partial functional specialization suggested by evidence of enhanced regulation during viral infection. The protein is predicted to be secreted and localized to extracellular compartments, likely at barrier organ sites including respiratory epithelium where immune regulation and pathogen detection intersect. The broad tissue and cellular distribution of SCGB1C2 expression across immune cells and epithelial tissues suggests participation in coordinated regulation of innate immune responses and epithelial barrier function. The association with inflammatory spondylopathy, shared with its paralog SCGB1C1, indicates potential dysregulation in immune-mediated inflammatory joint diseases, though the specific mechanistic contributions remain to be elucidated. The emerging evidence of critical regulatory function during early viral infection identifies SCGB1C2 as a potential therapeutic target for enhancing antiviral defenses and improving outcomes in severe viral infections, suggesting clinical translation potential for SCGB1C2-directed therapeutics.

The fundamental similarities to other secretoglobin family members in structural organization and predicted ligand-binding capacity suggest that SCGB1C2 likely functions through mechanisms involving steroids, phospholipids, or eicosanoid binding and presentation, though direct biochemical confirmation remains necessary. The redox-dependent regulation of disulfide bonds and potential for ligand binding suggest that SCGB1C2 might serve as an environment-responsive immunoregulatory protein capable of dynamic modulation of immune responses based on local tissue redox state and inflammatory status. Integration with innate immune sensing pathways, particularly those regulating type I interferon responses, represents a plausible functional role that aligns with evidence of viral infection response regulation while remaining speculative without direct experimental confirmation.

Research Priorities and Outstanding Questions

Several important questions remain regarding SCGB1C2 biology and warrant directed investigation. First, definitive characterization of SCGB1C2 protein structure through crystallographic analysis or cryo-electron microscopy would clarify the precise geometry of the putative ligand-binding cavity and identify critical residues for ligand interaction. Second, biochemical identification of natural ligands bound by SCGB1C2, through binding assays with purified recombinant protein and panels of potential ligands, would establish the molecular basis for SCGB1C2 function and identify mechanistic targets for therapeutic intervention. Third, comprehensive investigation of SCGB1C2 regulation by inflammatory and anti-inflammatory cytokines would establish its integration into T cell response pathways and identify triggers for altered SCGB1C2 expression in immune-mediated diseases. Fourth, functional studies examining the specific roles of SCGB1C2 in viral infection models, through approaches including overexpression and genetic deletion studies, would quantify the contribution of SCGB1C2 to antiviral immunity and identify downstream mechanisms of viral response regulation.

Fifth, investigation of SCGB1C2 expression patterns and functional consequences in inflammatory spondylopathy and related autoimmune conditions would clarify the pathogenic involvement of SCGB1C2 and potential for development of SCGB1C2-targeted therapeutics for these diseases. Sixth, comparative functional analysis with SCGB1C1 and other secretoglobin family members would establish the degree of functional redundancy versus specialization within the secretoglobin family and identify unique roles for SCGB1C2. Finally, therapeutic exploration of SCGB1C2 administration in experimental models of severe viral infection and immunodeficiency would test the translational potential of SCGB1C2-based therapeutics suggested by current functional evidence. These investigations would collectively advance from the current state of limited functional characterization toward comprehensive understanding of SCGB1C2 biology and clinical applicability.

Citations

1. https://maayanlab.cloud/Harmonizome/gene/SCGB1C2
2. https://amigo.geneontology.org/amigo/gene_product/UniProtKB:P0DMR2
3. https://platform.opentargets.org/target/ENSG00000268320?from=genetics
4. https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C2
5. https://enkilife.com/article/view/71777
6. https://diseases.jensenlab.org/Entity?documents=10&type1=9606&id1=ENSP00000471646&type2=-26&id2=DOID%3A12105
7. https://onlinelibrary.wiley.com/doi/10.1111/all.15033
8. https://en.wikipedia.org/wiki/Secretoglobin
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC11173076/
10. http://biogps.org/gene/653486/
11. https://www.uniprot.org/uniprotkb/Q8TD33/entry
12. https://patents.google.com/patent/EP4499149A1/en
13. https://www.uniprot.org/uniprot/P0DMR2-1
14. https://patents.google.com/patent/US20200347045A1/en
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC7402632/
16. https://pmc.ncbi.nlm.nih.gov/articles/PMC3063214/
17. https://pmc.ncbi.nlm.nih.gov/articles/PMC6542149/
18. https://pmc.ncbi.nlm.nih.gov/articles/PMC10361255/
19. https://www.proteinatlas.org/ENSG00000268320-SCGB1C2/single+cell
20. https://patents.justia.com/patent/11932635
21. https://pmc.ncbi.nlm.nih.gov/articles/PMC9271138/
22. https://maayanlab.cloud/Harmonizome/search?q=Glycosyl+transferase%2C+family+10
23. https://patents.google.com/patent/WO2016141387A1/en
24. https://pmc.ncbi.nlm.nih.gov/articles/PMC12309595/
25. https://pmc.ncbi.nlm.nih.gov/articles/PMC3251818/
26. https://patents.google.com/patent/US20210363525A1/en
27. https://pmc.ncbi.nlm.nih.gov/articles/PMC7032534/
28. https://pmc.ncbi.nlm.nih.gov/articles/PMC7177344/
29. https://pubmed.ncbi.nlm.nih.gov/23198756/
30. http://www.signalingpathways.org/ominer/query.jsf?geneSearchType=gene&findMax=y&gene=SCGB1C2&species=all&reportsBy=pathways&omicsCategory=cistromics&countMax=3000
31. https://patents.justia.com/patent/20180305689
32. https://pmc.ncbi.nlm.nih.gov/articles/PMC10110710/
33. https://pmc.ncbi.nlm.nih.gov/articles/PMC2912657/
34. https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1A1
35. https://pmc.ncbi.nlm.nih.gov/articles/PMC5661633/
36. https://pmc.ncbi.nlm.nih.gov/articles/PMC7073184/
37. https://pmc.ncbi.nlm.nih.gov/articles/PMC21351/
38. https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1C1
39. https://pmc.ncbi.nlm.nih.gov/articles/PMC10350828/
40. https://synapse.patsnap.com/article/what-are-secretoglobin-stimulators-and-how-do-they-work